Evidence map›Paper›PMID 37142733›Full record

Trial reportDysphagia2023

Single-Versus Multiple-Dose Antimicrobial Prophylaxis in Peroral Endoscopic Myotomy: A Randomized Controlled Study (SMAPP Trial).

Zaheer Nabi, Bhushan Bhaware, Mohan Ramchandani, Jahangeer Basha, Pradev Inavolu, Rama Kotla, Rajesh Goud, Santosh Darisetty, Duvvur Nageshwar Reddy

Registry-linked trialAbstract readRandomized Controlled TrialEquivalence Trial
PubMed Publisher
In one paragraph

Trial report in Dysphagia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03784365 (Randomized Control Study Comparing Single-Versus Multiple-dose Antimicrobial Prophylaxis for Peroral Endoscopic Myotomy in Achalasia), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03784365 phase3unknown statusnot on this map

Randomized Control Study Comparing Single-Versus Multiple-dose Antimicrobial Prophylaxis for Peroral Endoscopic Myotomy in Achalasia

TypeinterventionalSponsorAsian Institute of Gastroenterology, IndiaRan2018 to 2020Enrolled40ConditionsAchalasia CardiaArmsOne dose of Cefo-perazone Sulbactum
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Saudi Gastroenterology Association (SGA) clinical care pathway and standards of care for peroral endoscopic myotomy (POEM) in achalasia.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Zaheer NabiDepartment of Gastroenterology, Asian Institute of Gastroenterology, Hyderabad, India. Zaheernabi1978@gmail.com.ORCID 0000-0003-2713-4781
Bhushan BhawareDepartment of Gastroenterology, Asian Institute of Gastroenterology, Hyderabad, India.
Mohan RamchandaniDepartment of Gastroenterology, Asian Institute of Gastroenterology, Hyderabad, India.
Jahangeer BashaDepartment of Gastroenterology, Asian Institute of Gastroenterology, Hyderabad, India.
Pradev InavoluDepartment of Gastroenterology, Asian Institute of Gastroenterology, Hyderabad, India.
Rama KotlaDepartment of Gastroenterology, Asian Institute of Gastroenterology, Hyderabad, India.
Rajesh GoudDepartment of Gastroenterology, Asian Institute of Gastroenterology, Hyderabad, India.
Santosh DarisettyDepartment of Gastroenterology, Asian Institute of Gastroenterology, Hyderabad, India.
Duvvur Nageshwar ReddyDepartment of Gastroenterology, Asian Institute of Gastroenterology, Hyderabad, India.
Asian Institute of Gastroenterology · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infections are uncommon after peroral endoscopic myotomy (POEM) procedure. However, prophylactic antibiotics are routinely administered for variable duration during peri-operative period. In this study, we aimed to determine the difference in the rate of infections between single (SD-A) and multiple doses (MD-A) antibiotic prophylaxis groups. The study was a prospective, randomized, non-inferiority trial conducted at a single tertiary care centre from Dec 2018 to Feb 2020. Eligible patients undergoing POEM were randomized into SD-A and MD-A groups. SD-A group received one dose of antibiotic (IIIrd gen cephalosporin) within 30-min of POEM. In the MD-A group, the same antibiotic was administered for a total of three days. Primary aim of the study was to determine the incidence of infections in the two groups. Secondary outcomes included incidence of fever (> 100 °F), inflammatory markers [erythrocyte sedimentation rate (ESR), c-reactive protein(CRP)], serum procalcitonin and adverse events related to antibiotics. (NCT03784365). 114 patients were randomized to SD-A (57) and MD-A (57) antibiotic groups. Mean post-POEM CRP (0.8 ± 0.9 vs 1.5 ± 1.6), ESR (15.8 ± 7.8 20.6 ± 11.7) and procalcitonin (0.05 ± 0.04 0.29 ± 0.58) were significantly higher after POEM (p = 0.001). Post-POEM inflammatory markers (ESR, CRP and procalcitonin) were similar in both the groups. Fever on day-0 (10.5% vs 14%) and day-1 (1.7% vs 3.5%) was detected in similar proportion of patients. Post-POEM infections were recorded in 3.5% (1.7% vs 5.3%, p = 0.618). Single dose of antibiotic is non-inferior to multiple dose antibiotic prophylaxis. Elevation of inflammatory markers and fever after POEM represents inflammation and does not predict infection after POEM.

Indexed as

Esophageal AchalasiaMyotomyNatural Orifice Endoscopic SurgeryAnti-Bacterial AgentsEsophageal Sphincter, LowerHumansProcalcitoninProspective StudiesRetrospective StudiesTreatment OutcomeAnti-Bacterial AgentsProcalcitoninAchalasiaAntibioticsEndoscopyMyotomy

Identifiers

PMID37142733
OpenAlexW4368347023

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.